Education and Training
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
SPECIFIC STUDY AIMS
1. To evaluate congruence between pelvic anatomical structures segmented on MRI and/or CT scans co-registered with transperineal US scans acquired with an optically and/or electromagnetically tracked matrix array ultrasound transducer.
2. To estimate the achievable accuracy of anatomy tracking based on 3D US matrix-array transducer imaging and grey-level based image registration algorithms.
Stanford is currently not accepting patients for this trial.
Eligibility
Inclusion Criteria:
- Men that will undergo prostate radiotherapy as a primary treatment or
post-prostatectomy.
- Age 18 or older
- Ability to understand and sign informed consent
Exclusion Criteria:
- Younger than 18 yrs old
- Inability to provide written and spoken consent.
- Patients with implanted actively controlled devices that may be subject to
electromagnetic interference from the UroNav/PervuNav electromagnetic tracking used in
the study.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Male
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
CCTO
650-498-7061
Not Recruiting